Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Vaxcyte Inc., 3 years.
Vaxcyte Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2025 | COMPASS Pathways Plc | Grant or award | +25,000 | — | — |
| Mar 3, 2025 | COMPASS Pathways Plc | Shares withheld for tax | −4,468 | $3.67 | $16,398 |
| Sep 17, 2024 | Vaxcyte Inc. | Option exercise | +6,250 | $22.70 | $141,875 |
| Sep 17, 2024 | Vaxcyte Inc. | Open-market sale | −241 | $114.64 | $27,628 |
| Sep 17, 2024 | Vaxcyte Inc. | Open-market sale | −1,445 | $115.32 | $166,637 |
| Sep 17, 2024 | Vaxcyte Inc. | Open-market sale | −4,308 | $116.62 | $502,399 |
| Sep 17, 2024 | Vaxcyte Inc. | Open-market sale | −256 | $117.51 | $30,083 |
| Jun 6, 2024 | Vaxcyte Inc. | Grant or award | +1,550 | — | — |
| Mar 1, 2024 | COMPASS Pathways Plc | Grant or award | +62,718 | — | — |
| Jun 13, 2023 | Vaxcyte Inc. | Grant or award | +2,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.